Medicare Bill Contains Significant Changes for Drug Manufacturers

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-01-02-2004, Volume 28, Issue 1

The new Medicare bill affects pricing and coverage, revises payment formula, and clarifies generic patent issues.

Related Content:

Regulatory WatchPharmaceutical Technology-01-02-2004
Vaccine Development Builds on COVID-19 Breakthroughs
FDA Interactions with Industry Under Scrutiny
A Rocky Road Ahead for FDA and Industry